Regulatory Affairs
FDA Announces Issuance of Priority Review Voucher for Rare Pediatric Disease Product FAYUVI
The U.S. Food and Drug Administration released a notice that it is granting a priority review voucher to the sponsor of the rare pediatric disease product application for FAYUVI (rebisufligene etisparvovec‑hopf). The…
1 source4 claims checked8h ago
4 unverifiable
Biblical perspectiveINSUFFICIENT CONTEXT
Full analysis